SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-024587
Filing Date
2022-09-08
Accepted
2022-09-08 15:59:22
Documents
14
Period of Report
2022-09-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20220908.htm   iXBRL 8-K 41306
2 EX-99.1 csbr8-k7312022ex991xq123.htm EX-99.1 125623
6 GRAPHIC logobranding_headerleftalia.jpg GRAPHIC 32167
  Complete submission text file 0001628280-22-024587.txt   346361

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20220908.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20220908_lab.xml EX-101.LAB 22080
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20220908_pre.xml EX-101.PRE 11532
8 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20220908_htm.xml XML 9792
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 221233814
SIC: 2836 Biological Products, (No Diagnostic Substances)